Birgitta Versluijs

104 tory disease in hematopoietic cell trans- plant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomes. Clin Infect Dis 2013; 57(12): 1731-41. 15. El-Bietar J, Nelson A, Wallace G, et al. RSV infection without ribavirin treat- ment in pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant 2016; 51(10): 1382-4. 16. Teusink-Cross A, Davies SM, Danziger- Isakov L, El-Bietar J, Grimley MS. Res- trictive Palivizumab Use Does Not Lead to Increased Morbidity and Mortality in Pediatric Hematopoietic Stem Cell Transplantation Patients. Biol Blood Marrow Transplant 2016; 22(10): 1904- 6. 17. Mendes ET, Ramos J, Peixoto D, et al. An outbreak of respiratory syncytial vi- rus infection in hematopoietic stem cell transplantation outpatients: good outcome without specific antiviral tre- atment. Transpl Infect Dis 2013; 15(1): 42-8. 18. Russell CD, Unger SA, Walton M, Schwarze J. The Human Immune Res- ponse to Respiratory Syncytial Virus In- fection. Clin Microbiol Rev 2017; 30(2): 481-502. 19. Versluys B, Bierings M, Murk JL, et al. Infection with a respiratory virus before hematopoietic cell transplantation is associated with alloimmune-mediated lung syndromes. J Allergy Clin Immunol 2017. 6